Boston Scientific Dirección
Dirección controles de criterios 3/4
Boston Scientific's El consejero delegado es Mike Mahoney , nombrado en Oct 2011, tiene un mandato de 12.17 años. la remuneración anual total es $16.94M , compuesta por 8.2% salario y 91.8% primas, incluidas acciones y opciones de la empresa. posee directamente 0.11% de las acciones de la empresa, por valor de $92.57M . La antigüedad media del equipo directivo y del consejo de administración es de 8 años y 8.7 años respectivamente.
Información clave
Mike Mahoney
Chief Executive Officer (CEO)
US$18.7m
Compensación total
| Porcentaje del salario del CEO | 7.5% |
| Permanencia del CEO | 12.5yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 7.8yrs |
| Promedio de permanencia en la Junta Directiva | 9yrs |
Actualizaciones recientes de la dirección
Recent updates
Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
Apr 05A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Mar 26
We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease
Feb 29What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E
Feb 15Is Boston Scientific (NYSE:BSX) A Risky Investment?
Feb 02Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital
Jan 19Boston Scientific: Portfolio Updates Driving Top-Line Growth
Jan 17Boston Scientific: Continued M&A Drives More Growth
Jan 10Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?
Dec 04Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?
Nov 03Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue
Oct 30ADVENT Offers Up An Early Present For Boston Scientific Investors
Aug 28Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Aug 24Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly
Jul 25Boston Scientific Remains Operationally Sound But May Have Limited Upside
Jul 14Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital
Jul 10Boston Scientific Corporation (NYSE:BSX) Shares Could Be 29% Above Their Intrinsic Value Estimate
May 21Here's Why Boston Scientific (NYSE:BSX) Can Manage Its Debt Responsibly
Apr 18Returns On Capital At Boston Scientific (NYSE:BSX) Paint A Concerning Picture
Apr 03Boston Scientific Stands Out With Strong, Diversified Growth Profile
Feb 15Boston Scientific Non-GAAP EPS of $0.45 misses by $0.02, revenue of $3.24B in-line
Feb 01Boston Scientific sees double digit EPS growth in 2023 - JPMorgan Healthcare conference
Jan 11Boston Scientific to acquire majority stake of Acotec Scientific
Dec 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$19m | US$1m | US$2b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$861m |
| Mar 31 2023 | n/a | n/a | US$846m |
| Dec 31 2022 | US$17m | US$1m | US$642m |
| Sep 30 2022 | n/a | n/a | US$596m |
| Jun 30 2022 | n/a | n/a | US$828m |
| Mar 31 2022 | n/a | n/a | US$754m |
| Dec 31 2021 | US$16m | US$1m | US$985m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$526m |
| Mar 31 2021 | n/a | n/a | US$201m |
| Dec 31 2020 | US$14m | US$667k | -US$115m |
| Sep 30 2020 | n/a | n/a | US$4b |
| Jun 30 2020 | n/a | n/a | US$4b |
| Mar 31 2020 | n/a | n/a | US$4b |
| Dec 31 2019 | US$16m | US$1m | US$5b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$14m | US$1m | US$2b |
| Sep 30 2018 | n/a | n/a | US$670m |
| Jun 30 2018 | n/a | n/a | US$521m |
| Mar 31 2018 | n/a | n/a | US$112m |
| Dec 31 2017 | US$13m | US$1m | US$104m |
Compensación vs. Mercado: Mike($USD16.94M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD12.14M).
Compensación vs. Ingresos: La compensación de Mike ha sido consistente con los resultados de la empresa en el último año.
CEO
Mike Mahoney (58 yo)
12.5yrs
Permanencia
US$18,723,735
Compensación
Mr. Michael F. Mahoney, also known as Mike, has been Independent Director of CVS Health Corporation since November 01, 2023. He has been Chairman of Boston Scientific Corporation since May 3, 2016, and is...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 12.5yrs | US$18.72m | 0.13% $ 131.6m | |
| Executive VP & CFO | 10.3yrs | US$5.83m | 0.018% $ 18.6m | |
| Executive VP & Group President of Cardiology | 14.2yrs | US$5.59m | 0.013% $ 13.6m | |
| Executive VP & President of Peripheral Interventions | 11.3yrs | US$3.78m | 0.0040% $ 4.0m | |
| Executive VP and Group President of MedSurg & Asia Pacific | 7.8yrs | US$4.27m | 0.0023% $ 2.3m | |
| Independent Director | no data | US$340.00k | 0.0050% $ 5.1m | |
| Executive Vice President of Global Operations | 1.9yrs | sin datos | 0.0034% $ 3.5m | |
| Senior VP | less than a year | sin datos | 0.00026% $ 262.5k | |
| Senior VP and Chief Information & Digital Officer | 8.3yrs | sin datos | sin datos | |
| Senior VP of Investor Relations | less than a year | sin datos | 0.0026% $ 2.6m | |
| Senior VP | 2.8yrs | sin datos | 0.0022% $ 2.2m | |
| Senior VP of Market Access & Chief Marketing Officer | 2.9yrs | sin datos | sin datos |
7.8yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: BSXEl equipo directivo de la empresa es veterano y experimentado (8 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 11.4yrs | US$18.72m | 0.13% $ 131.6m | |
| Independent Director | 10.3yrs | US$340.00k | 0.0050% $ 5.1m | |
| Lead Independent Director | 10.1yrs | US$360.00k | 0.0023% $ 2.4m | |
| Independent Director | 8yrs | US$335.00k | 0.0031% $ 3.1m | |
| Independent Director | 7.8yrs | US$320.00k | sin datos | |
| Independent Director | 2.8yrs | US$338.75k | 0.0025% $ 2.5m | |
| Independent Director | 9yrs | US$326.25k | 0.0043% $ 4.4m | |
| Independent Director | 14.3yrs | US$340.22k | 0.0024% $ 2.5m | |
| Independent Director | 15yrs | US$340.00k | 0.0034% $ 3.4m | |
| Independent Director | less than a year | US$233.23k | 0.00022% $ 222.1k | |
| Independent Director | less than a year | US$233.23k | 0.00014% $ 141.4k |
9.0yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de BSX se considera experimentada (8.7 años de antigüedad promedio).